Roberts Christopher J
Department of Chemical Engineering, University of Delaware, Newark, Delaware 19716, USA.
Biotechnol Bioeng. 2007 Dec 1;98(5):927-38. doi: 10.1002/bit.21627.
Experimental kinetics of non-native protein aggregation are of practical importance in that they help dictate viable processing, formulation, and storage conditions for biotechnology products, and appear to play a role in determining the onset of a number of diseases. Fundamentally, aggregation kinetics provide insights into the identity of key intermediates in the process, and quantitative tests of available models of aggregation. Although aggregation kinetics often display seemingly disparate behaviors across different proteins and sample conditions, this review illustrates how many of these can be understood within a general framework that treats aggregation as a multi-stage process, and how most available kinetic models of aggregation can be grouped hierarchically in terms of which stage(s) they include. This provides an aid for workers seeking a mechanistic interpretation of in vitro aggregation kinetics, for discriminating among competing models, and in designing experiments to assess in vitro protein stability. Limitations and the utility of purely kinetic approaches to studying aggregation, clarifications of common misperceptions regarding experimental aggregation kinetics, and some outstanding challenges in the field are briefly discussed.
非天然蛋白质聚集的实验动力学具有实际重要性,因为它们有助于确定生物技术产品可行的加工、配方和储存条件,并且似乎在许多疾病的发病过程中起作用。从根本上说,聚集动力学能深入了解该过程中关键中间体的特性,以及对现有聚集模型进行定量测试。尽管聚集动力学在不同蛋白质和样品条件下常常表现出看似不同的行为,但本综述阐述了如何在将聚集视为多阶段过程的通用框架内理解其中许多行为,以及如何根据所包含的阶段对大多数现有的聚集动力学模型进行层次分类。这有助于研究人员对体外聚集动力学进行机理解释、区分相互竞争的模型以及设计实验来评估体外蛋白质稳定性。本文还简要讨论了纯动力学方法在研究聚集方面的局限性和实用性,澄清了关于实验聚集动力学的常见误解,以及该领域一些突出的挑战。